Search research articles
Contact Us
Filters
Showing results (11-20 of 339) with videos related to
Page
of 34
Sort By:
Chest
|
August 12, 2009
Improving the standard of care for patients with idiopathic pulmonary fibrosis requires participation in clinical trials
Ganesh Raghu,
The Lancet. Respiratory Medicine
|
September 7, 2016
Anti-acid treatment in patients with IPF: interpret results from post-hoc, subgroup, and exploratory analyses with great caution
Ganesh Raghu
The New England Journal of Medicine
|
February 20, 2020
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Ganesh Raghu
American Journal of Respiratory and Critical Care Medicine
|
April 2, 2016
Reply: Can Warfarin Be Used in the Treatment of Pulmonary Embolism in Idiopathic Pulmonary Fibrosis?
Bram Rochwerg, Ganesh Raghu
The European Respiratory Journal
|
April 3, 2016
Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened
Bridget Collins, Ganesh Raghu
The European Respiratory Journal
|
November 30, 2018
Idiopathic pulmonary fibrosis: unmasking cryptogenic environmental factors
Coralynn Sack, Ganesh Raghu
Respirology (Carlton, Vic.)
|
May 4, 2023
Hypersensitivity pneumonitis: Principles in diagnosis and management
Suha Kadura, Ganesh Raghu
Respiratory Medicine
|
July 23, 2017
Current approaches to the management of idiopathic pulmonary fibrosis
Ganesh Raghu, Luca Richeldi
The European Respiratory Journal
|
June 23, 2018
Gastro-oesophageal reflux and idiopathic pulmonary fibrosis: the heart burn in patients with IPF can no longer be silent
Michael Kreuter, Ganesh Raghu
American Journal of Respiratory and Critical Care Medicine
|
January 14, 2017
Reply: Can Bisphosphonates Prevent Vitamin K Antagonist Toxicity in Patients with Idiopathic Pulmonary Fibrosis?
Ganesh Raghu, Bram Rochwerg
Page
of 34
Search research articles
Search
Showing results (11-20 of 339) with videos related to
Sort By:
Page
of 34
Chest
|
August 12, 2009
Improving the standard of care for patients with idiopathic pulmonary fibrosis requires participation in clinical trials
Ganesh Raghu,
The Lancet. Respiratory Medicine
|
September 7, 2016
Anti-acid treatment in patients with IPF: interpret results from post-hoc, subgroup, and exploratory analyses with great caution
Ganesh Raghu
The New England Journal of Medicine
|
February 20, 2020
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Ganesh Raghu
American Journal of Respiratory and Critical Care Medicine
|
April 2, 2016
Reply: Can Warfarin Be Used in the Treatment of Pulmonary Embolism in Idiopathic Pulmonary Fibrosis?
Bram Rochwerg, Ganesh Raghu
The European Respiratory Journal
|
April 3, 2016
Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened
Bridget Collins, Ganesh Raghu
The European Respiratory Journal
|
November 30, 2018
Idiopathic pulmonary fibrosis: unmasking cryptogenic environmental factors
Coralynn Sack, Ganesh Raghu
Respirology (Carlton, Vic.)
|
May 4, 2023
Hypersensitivity pneumonitis: Principles in diagnosis and management
Suha Kadura, Ganesh Raghu
Respiratory Medicine
|
July 23, 2017
Current approaches to the management of idiopathic pulmonary fibrosis
Ganesh Raghu, Luca Richeldi
The European Respiratory Journal
|
June 23, 2018
Gastro-oesophageal reflux and idiopathic pulmonary fibrosis: the heart burn in patients with IPF can no longer be silent
Michael Kreuter, Ganesh Raghu
American Journal of Respiratory and Critical Care Medicine
|
January 14, 2017
Reply: Can Bisphosphonates Prevent Vitamin K Antagonist Toxicity in Patients with Idiopathic Pulmonary Fibrosis?
Ganesh Raghu, Bram Rochwerg
Page
of 34